HER-2 can be heralded as a prognostic factor, as higher levels of this EGFR in serum seem to be associated with more severe disease; lymph node involvement, distant metastasis, increased tumor size and higher TNM stages of SCC. This evidence concerns the gene ERBB2 and neoplasm.